Several reports are reviews rather than primary studies, and many abstracts do not report detailed safety, adherence, or follow-up data
If a provider publishes processing timeframes and verification steps up front, that is a positive signal
Meanwhile, participants with severe obesity and established cardiovascular disease in TRIUMPH-3 lost up to 22.6% of their body weight at 80 weeks
In a statement published alongside the results, Amgen said: Weight loss had not plateaued by 52 weeks, indicating the potential for further weight reduction. It added that improvements were recorded across other cardiometabolic measures, including waist circumference, blood pressure, high-sensitivity C-reactive protein (hs-CRP) and select lipid parameters
At this time, a healthcare professional will conduct a detailed assessment of your weight loss attempts, lifestyle, goals, medical history, and preferences regarding weight management